Data Magik Ltd   Report issue

For profit Phase 2
Founded: Wiltshire United Kingdom (1999)

Organization Overview

First Clinical Trial
2019
NCT03794557
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Data Magik Limited | Data Magik Ltd

Active Ingredients

Drugs in Phase 2 Trials (2)

nicardipine (cardene) (1 trial)

pul-042 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 2)

Hemorrhage (Phase 2)

Subarachnoid Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2